Author

Theodoros Kelesidis

Infectious Diseases Physician, UCLA Medical Center - Cited by 9,612 - Infectious Diseases - HIV - Immunology - Metabolic complications of chronic infections - antimicrobial resistance

Biography

Theodoros Kelesidis, MD, serves as Infectious Diseases Physician at the Division of Infectious Diseases at UCLA Medical Center. His research focuses on immunology, infectious diseases, and metabolic complications of infectious diseases including HIV infection. Dr. Kelesidis is a graduate of the University of Athens Medical School and Board certified in Internal Medicine and Infectious Diseases. He is recognized as an international expert on infectious diseases, is a reviewer in several scientific journals and has published numerous original papers, chapters, and reviews, and has received numerous citations.
Title
Cited by
Year
Sudden cardiac arrest in a patient with myxedema coma and COVID-19
NM Dixit, KP Truong, SV Rabadia, D Li, PK Srivastava, T Mosaferi, ...Journal of the Endocrine Society 4 (10), bvaa130, 2020202
22
2020
Elevated cellular oxidative stress in circulating immune cells in otherwise healthy young people who use electronic cigarettes in a cross‐sectional single‐center study …
T Kelesidis, E Tran, S Arastoo, K Lakhani, R Heymans, J Gornbein, ...Journal of the American Heart Association 9 (18), e016983, 2020202
21
2020
Update in viral infections in the intensive care unit
PC Fragkou, CD Moschopoulos, E Karofylakis, T Kelesidis, S TsiodrasFrontiers in Medicine 8, 575580, 2021202
13
2021
High‐density lipoprotein lipid peroxidation as a molecular signature of the risk for developing cardiovascular disease: Results from MASHAD cohort
S Samadi, M Mehramiz, T Kelesidis, MG Mobarhan, AH Sahebkar, ...Journal of cellular physiology 234 (9), 16168-16177, 2019201
10
2019
Expression of key inflammatory proteins is increased in immune cells from tobacco cigarette smokers but not electronic cigarette vapers: implications for atherosclerosis
T Kelesidis, Y Zhang, E Tran, G Sosa, HR MiddlekauffJournal of the American Heart Association 10 (1), e01324, 2021202
9
2021
Adipokines, weight gain and metabolic and inflammatory markers after antiretroviral therapy initiation: AIDS Clinical Trials Group (ACTG) A5260s
JR Koethe, C Moser, TT Brown, JH Stein, T Kelesidis, M Dube, J Currier, ...Clinical Infectious Diseases 74 (5), 57-64, 2022202
8
2022
Electronic and tobacco cigarettes alter polyunsaturated fatty acids and oxidative biomarkers
R Gupta, Y Lin, K Luna, A Logue, AJ Yoon, KP Haptonstall, R Moheimani, ...Circulation Research 129 (5), 514-526, 2021202
7
2021
Association of 1 vaping session with cellular oxidative stress in otherwise healthy young people with no history of smoking or vaping: a randomized clinical crossover trial
T Kelesidis, E Tran, R Nguyen, Y Zhang, G Sosa, HR MiddlekauffJAMA pediatrics 15 (11), 114-116, 2021202
7
2021
ApoA-I mimetics reduce systemic and gut inflammation in chronic treated HIV
M Daskou, W Mu, M Sharma, H Vasilopoulos, R Heymans, E Ritou, ...PLoS pathogens 18 (1), e1010160, 2022202
5
2022
ApoA-I mimetics attenuate macrophage activation in chronic treated HIV
MU William, M Sharma, R Heymans, E Ritou, V Rezek, P Hamid, ...AIDS (London, England) 3 (4), 43, 2021202
5
2021
The ApoA-I mimetic peptide 4F attenuates in vitro replication of SARS-CoV-2, associated apoptosis, oxidative stress and inflammation in epithelial cells
T Kelesidis, M Sharma, A Petcherski, C Hugo, E O’Connor, NW Hultgren, ...Virulence 12 (1), 2214-2227, 2021202
5
2021
Instigators of COVID-19 in Immune Cells Are Increased in Tobacco Cigarette Smokers and Electronic Cigarette Vapers Compared With Nonsmokers
T Kelesidis, Y Zhang, E Tran, G Sosa, HR MiddlekauffNicotine and Tobacco Research 24 (3), 413-41, 2022202
5
2022
Race and sex differences in HDL peroxide content among American adults with and without type 2 diabetes
SM Flaherty, EK Wood, CD Ryff, GD Love, T Kelesidis, L Berkowitz, ...Lipids in Health and Disease 21 (1), 1-12, 2022202
5
2022
ApoA-I mimetics favorably impact cyclooxygenase 2 and bioactive lipids that may contribute to cardiometabolic syndrome in chronic treated HIV
M Daskou, M Sharma, W Mu, R Heymans, E Ritou, V Rezek, P Hamid, ...Metabolism 12, 15888, 2021202
4
2021
Cross-talk between SARS-CoV-2 infection and the insulin/IGF signaling pathway: Implications for metabolic diseases in COVID-19 and for post-acute sequelae of SARS-CoV-2 infection
T Kelesidis, CS MantzorosMetabolism-Clinical and Experimental 13, 2022202
4
2022
Increased expression of proatherogenic proteins in immune cell subtypes in tobacco cigarette smokers but not in electronic cigarette vapers
T Kelesidis, Y Zhang, E Tran, G Sosa, HR MiddlekauffCanadian Journal of Cardiology 37 (8), 1175-1180, 2021202
4
2021
The role of oxidative stress in the pathogenesis of infections with coronaviruses
C Gain, S Song, T Angtuaco, S Satta, T KelesidisFrontiers in microbiology 13, 1111930, 2023202
4
2023
Mitoquinone mesylate targets SARS-CoV-2 and associated lung inflammation through host pathways
Mitoquinone mesylate targets SARS-CoV- and associated lung inflammation through host pathwaysA Petcherski, M Sharma, M Daskou, S Satta, H Vasilopoulos, C Hugo, ...bioRxiv, 0.0. .481100, 0
2
2022
Differential impact of chronic electronic cigarette and tobacco cigarette smoking on monocyte activation in humans
T Kelesidis, E Tran, K Lakhani, S Arastoo, R Heymans, H MiddlekauffJournal of the American College of Cardiology 75 (11_Supplement_1), 76-76, 000
2
2020
Greater IL-6, D-dimer, and ICAM-1 levels are associated with lower small HDL particle concentration in the Multicenter AIDS Cohort Study
S Sarkar, S Haberlen, S Whelton, E E Schneider, L Kingsley, F Palella, ...Open forum infectious diseases 6 (1), ofz474, 01901
2
2019

Referred From: https://scholar.google.com/citations?user=p5XTXbYAAAAJ&hl=en

Cited by
Citations 9612
h-index 44
i10-index 103
Recommended Journals
Open Access Journals